106015,1,Admission,O
106015,1,Date,O
106015,1,:,O
106015,1,[,O
106015,1,**2134-4-19**,O
106015,1,],O
106015,1,Discharge,O
106015,1,Date,O
106015,1,:,O
106015,1,[,O
106015,1,**2134-5-11**,O
106015,1,],O
106015,1,Date,O
106015,1,of,O
106015,1,Birth,O
106015,1,:,O
106015,1,[,O
106015,1,**2061-11-2**,O
106015,1,],O
106015,1,Sex,O
106015,1,:,O
106015,1,M,O
106015,1,Service,O
106015,1,:,O
106015,1,MEDICINE,O
106015,1,Allergies,O
106015,1,:,O
106015,1,Patient,O
106015,1,recorded,O
106015,1,as,O
106015,1,having,O
106015,1,No,O
106015,1,Known,O
106015,1,Allergies,O
106015,1,to,O
106015,1,Drugs,O
106015,1,Attending,O
106015,1,:,O
106015,1,[,O
106015,1,**First,O
106015,1,Name3,O
106015,1,(,O
106015,1,LF,O
106015,1,),O
106015,1,12131**,O
106015,1,],O
106015,1,Chief,O
106015,1,Complaint,O
106015,1,:,O
106015,1,Hypotension,O
106015,1,Major,O
106015,1,Surgical,O
106015,1,or,O
106015,1,Invasive,O
106015,1,Procedure,O
106015,1,:,O
106015,1,Endoscopy,O
106015,1,Sigmoidoscopy,O
106015,1,Portacath,O
106015,1,removal,O
106015,1,[,O
106015,1,**First,O
106015,1,Name3,O
106015,1,(,O
106015,1,LF,O
106015,1,),O
106015,1,**,O
106015,1,],O
106015,1,catheter,O
106015,1,placement,O
106015,1,[,O
106015,1,**First,O
106015,1,Name3,O
106015,1,(,O
106015,1,LF,O
106015,1,),O
106015,1,**,O
106015,1,],O
106015,1,History,O
106015,1,of,O
106015,1,Present,O
106015,1,Illness,O
106015,1,:,O
106015,1,72M,O
106015,1,with,O
106015,1,pmh,O
106015,1,significant,O
106015,1,for,O
106015,1,metastatic,O
106015,1,rectal,O
106015,1,cancer,O
106015,1,was,O
106015,1,at,O
106015,1,radiology,O
106015,1,clinic,O
106015,1,receiving,O
106015,1,scheduled,O
106015,1,imaging,O
106015,1,when,O
106015,1,blood,B-Reason
106015,1,pressure,I-Reason
106015,1,at,I-Reason
106015,1,triage,I-Reason
106015,1,recorded,I-Reason
106015,1,60/40,I-Reason
106015,1,.,O
106015,1,Recheck,O
106015,1,was,O
106015,1,70/40,O
106015,1,.,O
106015,1,His,O
106015,1,port,O
106015,1,was,O
106015,1,accessed,O
106015,1,and,O
106015,1,he,O
106015,1,was,O
106015,1,bolused,O
106015,1,with,O
106015,1,300cc,O
106015,1,of,O
106015,1,IVF,B-Drug
106015,1,and,O
106015,1,transferred,O
106015,1,to,O
106015,1,the,O
106015,1,ED,O
106015,1,.,O
106015,1,He,O
106015,1,denied,O
106015,1,syncope,O
106015,1,or,O
106015,1,lightheadedness,O
106015,1,but,O
106015,1,reported,O
106015,1,mild,O
106015,1,SOB,O
106015,1,and,O
106015,1,fatigue,O
106015,1,.,O
106015,1,He,O
106015,1,reports,O
106015,1,having,O
106015,1,several,O
106015,1,days,O
106015,1,of,O
106015,1,diahrrea,O
106015,1,",",O
106015,1,which,O
106015,1,began,O
106015,1,last,O
106015,1,wednesday,O
106015,1,[,O
106015,1,**4-14**,O
106015,1,],O
106015,1,.,O
106015,1,His,O
106015,1,last,O
106015,1,dose,O
106015,1,of,O
106015,1,irinotecan,B-Drug
106015,1,and,O
106015,1,panitumab,B-Drug
106015,1,chemotherapy,O
106015,1,was,O
106015,1,Monday,O
106015,1,[,O
106015,1,**2134-3-29**,O
106015,1,],O
106015,1,(,O
106015,1,patient,O
106015,1,reports,O
106015,1,was,O
106015,1,[,O
106015,1,**4-12**,O
106015,1,],O
106015,1,but,O
106015,1,not,O
106015,1,recorded,O
106015,1,in,O
106015,1,OMR,O
106015,1,),O
106015,1,",",O
106015,1,and,O
106015,1,he,O
106015,1,reports,O
106015,1,always,O
106015,1,getting,O
106015,1,diahrrea,B-ADE
106015,1,with,O
106015,1,his,O
106015,1,chemotherapy,B-Drug
106015,1,.,O
106015,1,He,O
106015,1,reports,O
106015,1,haveing,O
106015,1,watery,B-Reason
106015,1,bowel,I-Reason
106015,1,movements,I-Reason
106015,1,roughly,O
106015,1,every,O
106015,1,45,O
106015,1,minutes,O
106015,1,since,O
106015,1,wednesday,O
106015,1,.,O
106015,1,HIs,O
106015,1,bowel,O
106015,1,movements,O
106015,1,are,O
106015,1,not,O
106015,1,bloody,O
106015,1,or,O
106015,1,melanaic,O
106015,1,.,O
106015,1,He,O
106015,1,has,O
106015,1,been,O
106015,1,taking,O
106015,1,immodium,B-Drug
106015,1,and,O
106015,1,diphenoxylate-atropine,B-Drug
106015,1,without,O
106015,1,improvement,O
106015,1,.,O
106015,1,Sunday,O
106015,1,night,O
106015,1,",",O
106015,1,he,O
106015,1,reports,O
106015,1,acute,O
106015,1,worsening,O
106015,1,of,O
106015,1,his,O
106015,1,diahrrea,O
106015,1,",",O
106015,1,which,O
106015,1,continued,O
106015,1,through,O
106015,1,Monday,O
106015,1,.,O
106015,1,EMS,O
106015,1,gave,O
106015,1,him,O
106015,1,another,O
106015,1,500cc,O
106015,1,of,O
106015,1,NS,B-Drug
106015,1,prior,O
106015,1,to,O
106015,1,arrival,O
106015,1,to,O
106015,1,the,O
106015,1,ED,O
106015,1,.,O
106015,1,.,O
106015,1,On,O
106015,1,arrival,O
106015,1,to,O
106015,1,the,O
106015,1,ED,O
106015,1,his,O
106015,1,vitals,O
106015,1,were,O
106015,1,98.0,O
106015,1,100/50,O
106015,1,83,O
106015,1,18,O
106015,1,100,O
106015,1,%,O
106015,1,RA,O
106015,1,.,O
106015,1,Cr,O
106015,1,was,O
106015,1,1.3,O
106015,1,from,O
106015,1,1.1,O
106015,1,.,O
106015,1,Hct,O
106015,1,was,O
106015,1,27.3,O
106015,1,.,O
106015,1,Mg,O
106015,1,was,O
106015,1,0.8mg,O
106015,1,.,O
106015,1,He,O
106015,1,was,O
106015,1,guaiac,O
106015,1,negative,O
106015,1,.,O
106015,1,CT,O
106015,1,torso,O
106015,1,was,O
106015,1,without,O
106015,1,PE,O
106015,1,or,O
106015,1,dissection,O
106015,1,",",O
106015,1,but,O
106015,2,did,O
106015,2,have,O
106015,2,multiple,O
106015,2,stable,O
106015,2,pulmonary,O
106015,2,nodules,O
106015,2,",",O
106015,2,and,O
106015,2,a,O
106015,2,small,O
106015,2,right,O
106015,2,pleural,O
106015,2,effusion,O
106015,2,.,O
106015,2,He,O
106015,2,also,O
106015,2,had,O
106015,2,stable,O
106015,2,metastatic,O
106015,2,disease,O
106015,2,.,O
106015,2,EKG,O
106015,2,was,O
106015,2,sinus,O
106015,2,in,O
106015,2,the,O
106015,2,70,O
106015,2,'s,O
106015,2,.,O
106015,2,He,O
106015,2,was,O
106015,2,given,O
106015,2,3L,O
106015,2,of,O
106015,2,NS,B-Drug
106015,2,and,O
106015,2,4,O
106015,2,grams,O
106015,2,of,O
106015,2,Mg,B-Drug
106015,2,.,O
106015,2,.,O
106015,2,Review,O
106015,2,of,O
106015,2,Systems,O
106015,2,:,O
106015,2,(,O
106015,2,+,O
106015,2,),O
106015,2,Per,O
106015,2,HPI,O
106015,2,.,O
106015,2,He,O
106015,2,is,O
106015,2,denying,O
106015,2,fevers,O
106015,2,",",O
106015,2,abdominal,O
106015,2,pain,O
106015,2,",",O
106015,2,chest,O
106015,2,pain,O
106015,2,",",O
106015,2,hematochezia,O
106015,2,",",O
106015,2,melena,O
106015,2,.,O
106015,2,Past,O
106015,2,Medical,O
106015,2,History,O
106015,2,:,O
106015,2,Past,O
106015,2,Oncologic,O
106015,2,History,O
106015,2,:,O
106015,2,Adenocarcinoma,O
106015,2,of,O
106015,2,the,O
106015,2,rectum,O
106015,2,-,O
106015,2,[,O
106015,2,**6-/2131**,O
106015,2,],O
106015,2,:,O
106015,2,The,O
106015,2,patient,O
106015,2,presented,O
106015,2,with,O
106015,2,a,O
106015,2,change,O
106015,2,in,O
106015,2,bowel,O
106015,2,habits,O
106015,2,and,O
106015,2,was,O
106015,2,noted,O
106015,2,to,O
106015,2,have,O
106015,2,an,O
106015,2,abnormal,O
106015,2,rectal,O
106015,2,exam,O
106015,2,by,O
106015,2,his,O
106015,2,primary,O
106015,2,care,O
106015,2,physician,O
106015,2,",",O
106015,2,[,O
106015,2,**Name10,O
106015,2,(,O
106015,2,NameIs,O
106015,2,),O
106015,2,39262**,O
106015,2,],O
106015,2,[,O
106015,2,**Name,O
106015,2,Initial,O
106015,2,(,O
106015,2,NameIs,O
106015,2,),O
106015,2,**,O
106015,2,],O
106015,2,gastrointestinal,O
106015,2,evaluation,O
106015,2,.,O
106015,2,-,O
106015,2,[,O
106015,2,**2131-7-23**,O
106015,2,],O
106015,2,colonoscopy,O
106015,2,:,O
106015,2,Exophytic,O
106015,2,cancer,O
106015,2,of,O
106015,2,the,O
106015,2,rectum,O
106015,2,[,O
106015,2,**9-9**,O
106015,2,],O
106015,2,cm,O
106015,2,above,O
106015,2,the,O
106015,2,anal,O
106015,2,margin,O
106015,2,.,O
106015,2,Polyp,O
106015,2,noted,O
106015,2,at,O
106015,2,the,O
106015,2,anorectal,O
106015,2,junction,O
106015,2,.,O
106015,2,Biopsy,O
106015,2,:,O
106015,2,Invasive,O
106015,2,",",O
106015,2,moderately,O
106015,2,differentiated,O
106015,2,adenocarcinoma,O
106015,2,arising,O
106015,2,in,O
106015,2,association,O
106015,2,with,O
106015,2,adenoma,O
106015,2,.,O
106015,2,Polyp,O
106015,2,:,O
106015,2,Adenoma,O
106015,2,with,O
106015,2,high-grade,O
106015,2,dysplasia,O
106015,2,.,O
106015,2,-,O
106015,2,[,O
106015,2,**2131-7-25**,O
106015,2,],O
106015,2,rectal,O
106015,2,ultrasound,O
106015,2,:,O
106015,2,T3,O
106015,2,posterior,O
106015,2,midline,O
106015,2,tumor,O
106015,2,with,O
106015,2,luminal,O
106015,2,narrowing,O
106015,2,of,O
106015,2,the,O
106015,2,rectum,O
106015,2,.,O
106015,2,-,O
106015,2,[,O
106015,2,**2131-8-2**,O
106015,2,],O
106015,2,CT,O
106015,2,scan,O
106015,2,of,O
106015,2,the,O
106015,2,torso,O
106015,2,:,O
106015,2,Irregular,O
106015,2,",",O
106015,2,polypoid,O
106015,2,lesion,O
106015,2,seen,O
106015,2,within,O
106015,2,the,O
106015,2,rectum,O
106015,2,",",O
106015,2,with,O
106015,2,multiple,O
106015,2,subcentimeter,O
106015,2,presacral,O
106015,2,and,O
106015,2,pericolic,O
106015,2,lymph,O
106015,2,nodes,O
106015,2,identified,O
106015,2,.,O
106015,2,Two,O
106015,2,pulmonary,O
106015,2,nodules,O
106015,2,seen,O
106015,2,in,O
106015,2,the,O
106015,2,left,O
106015,2,lower,O
106015,2,lobe,O
106015,2,",",O
106015,2,the,O
106015,2,largest,O
106015,2,measuring,O
106015,2,2.9,O
106015,2,x,O
106015,2,2.2,O
106015,2,cm,O
106015,2,.,O
106015,2,Multiple,O
106015,2,low-attenuation,O
106015,2,lesions,O
106015,2,seen,O
106015,2,within,O
106015,2,the,O
106015,2,liver,O
106015,2,",",O
106015,2,the,O
106015,2,largest,O
106015,2,of,O
106015,2,which,O
106015,2,may,O
106015,2,represent,O
106015,2,cyst,O
106015,2,",",O
106015,2,smaller,O
106015,2,lesions,O
106015,2,are,O
106015,2,not,O
106015,2,fully,O
106015,2,characterized,O
106015,2,.,O
106015,2,Low-attenuation,O
106015,2,lesions,O
106015,2,seen,O
106015,2,within,O
106015,2,the,O
106015,2,left,O
106015,2,kidney,O
106015,2,",",O
106015,2,possibly,O
106015,2,a,O
106015,2,cyst,O
106015,2,",",O
106015,2,although,O
106015,2,too,O
106015,2,small,O
106015,2,to,O
106015,2,characterize,O
106015,2,.,O
106015,2,Per,O
106015,2,report,O
106015,2,",",O
106015,2,a,O
106015,2,CT,O
106015,2,PET,O
106015,2,performed,O
106015,2,elsewhere,O
106015,2,demonstrated,O
106015,2,uptake,O
106015,2,in,O
106015,2,the,O
106015,2,left,O
106015,2,base,O
106015,2,of,O
106015,2,the,O
106015,2,lung,O
106015,2,.,O
106015,2,-,O
106015,2,[,O
106015,2,**2131-8-14**,O
106015,3,],O
106015,3,to,O
106015,3,[,O
106015,3,**2131-9-25**,O
106015,3,],O
106015,3,:,O
106015,3,Neoadjuvant,O
106015,3,chemoradiation,O
106015,3,with,O
106015,3,continuous,O
106015,3,5-FU,O
106015,3,at,O
106015,3,225,O
106015,3,mg/m2/day,O
106015,3,and,O
106015,3,radiation,O
106015,3,therapy,O
106015,3,five,O
106015,3,days,O
106015,3,weekly,O
106015,3,.,O
106015,3,-,O
106015,3,[,O
106015,3,**2131-12-10**,O
106015,3,],O
106015,3,:,O
106015,3,Proctosigmoidectomy,O
106015,3,with,O
106015,3,stapled,O
106015,3,coloanal,O
106015,3,anastomosis,O
106015,3,and,O
106015,3,diverting,O
106015,3,loop,O
106015,3,ileostomy,O
106015,3,.,O
106015,3,Pathology,O
106015,3,revealed,O
106015,3,adenocarcinoma,O
106015,3,of,O
106015,3,the,O
106015,3,rectum,O
106015,3,",",O
106015,3,low-grade,O
106015,3,",",O
106015,3,with,O
106015,3,invasion,O
106015,3,into,O
106015,3,the,O
106015,3,perirectal,O
106015,3,adipose,O
106015,3,tissue,O
106015,3,and,O
106015,3,metastasis,O
106015,3,to,O
106015,3,7,O
106015,3,of,O
106015,3,13,O
106015,3,regional,O
106015,3,lymph,O
106015,3,nodes,O
106015,3,(,O
106015,3,T3N2,O
106015,3,),O
106015,3,.,O
106015,3,The,O
106015,3,resection,O
106015,3,margins,O
106015,3,were,O
106015,3,uninvolved,O
106015,3,.,O
106015,3,-,O
106015,3,[,O
106015,3,**2132-1-28**,O
106015,3,],O
106015,3,PET,O
106015,3,Scan,O
106015,3,:,O
106015,3,Interval,O
106015,3,progression,O
106015,3,of,O
106015,3,disease,O
106015,3,with,O
106015,3,an,O
106015,3,increase,O
106015,3,in,O
106015,3,the,O
106015,3,size,O
106015,3,of,O
106015,3,the,O
106015,3,previously,O
106015,3,identified,O
106015,3,lung,O
106015,3,metastasis,O
106015,3,.,O
106015,3,There,O
106015,3,is,O
106015,3,a,O
106015,3,new,O
106015,3,FDG-avid,O
106015,3,focus,O
106015,3,in,O
106015,3,segment,O
106015,3,4A,O
106015,3,of,O
106015,3,the,O
106015,3,liver,O
106015,3,which,O
106015,3,most,O
106015,3,likely,O
106015,3,represents,O
106015,3,metastasis,O
106015,3,.,O
106015,3,-,O
106015,3,[,O
106015,3,**2132-2-13**,O
106015,3,],O
106015,3,:,O
106015,3,Ileostomy,O
106015,3,takedown,O
106015,3,with,O
106015,3,simultaneous,O
106015,3,flexible,O
106015,3,bronchoscopy,O
106015,3,and,O
106015,3,VATS,O
106015,3,with,O
106015,3,left,O
106015,3,lower,O
106015,3,lobe,O
106015,3,resection,O
106015,3,.,O
106015,3,Pathology,O
106015,3,from,O
106015,3,the,O
106015,3,ileostomy,O
106015,3,stoma,O
106015,3,demonstrated,O
106015,3,no,O
106015,3,evidence,O
106015,3,of,O
106015,3,malignancy,O
106015,3,.,O
106015,3,The,O
106015,3,left,O
106015,3,lower,O
106015,3,lobe,O
106015,3,wedge,O
106015,3,resection,O
106015,3,demonstrated,O
106015,3,an,O
106015,3,adenocarcinoma,O
106015,3,",",O
106015,3,4.1,O
106015,3,cm,O
106015,3,",",O
106015,3,consistent,O
106015,3,with,O
106015,3,metastasis,O
106015,3,of,O
106015,3,rectal,O
106015,3,origin,O
106015,3,.,O
106015,3,The,O
106015,3,pleural,O
106015,3,and,O
106015,3,apparent,O
106015,3,stapled,O
106015,3,margins,O
106015,3,were,O
106015,3,free,O
106015,3,of,O
106015,3,malignancy,O
106015,3,.,O
106015,3,-,O
106015,3,[,O
106015,3,**2132-2-14**,O
106015,3,],O
106015,3,:,O
106015,3,Evaluation,O
106015,3,by,O
106015,3,the,O
106015,3,hepatobiliary,O
106015,3,surgery,O
106015,3,consult,O
106015,3,team,O
106015,3,due,O
106015,3,to,O
106015,3,the,O
106015,3,finding,O
106015,3,on,O
106015,3,his,O
106015,3,recent,O
106015,3,PET,O
106015,3,scan,O
106015,3,of,O
106015,3,a,O
106015,3,likely,O
106015,3,liver,O
106015,3,metastasis,O
106015,3,.,O
106015,3,It,O
106015,3,was,O
106015,3,felt,O
106015,3,that,O
106015,3,the,O
106015,3,lesion,O
106015,3,was,O
106015,3,amenable,O
106015,3,to,O
106015,3,surgical,O
106015,3,resection,O
106015,3,",",O
106015,3,and,O
106015,3,it,O
106015,3,was,O
106015,3,planned,O
106015,3,that,O
106015,3,the,O
106015,3,patient,O
106015,3,would,O
106015,3,undergo,O
106015,3,two,O
106015,3,cycles,O
106015,3,of,O
106015,3,chemotherapy,O
106015,3,prior,O
106015,3,to,O
106015,3,proceeding,O
106015,3,with,O
106015,3,hepatic,O
106015,3,resection,O
106015,3,.,O
106015,3,-,O
106015,3,[,O
106015,3,**2132-4-9**,O
106015,3,],O
106015,3,:,O
106015,3,FOLFOX,B-Drug
106015,3,chemotherapy,I-Drug
106015,3,initiated,O
106015,3,.,O
106015,3,The,O
106015,3,patient,O
106015,3,completed,O
106015,3,two,O
106015,3,cycles,O
106015,3,of,O
106015,3,therapy,O
106015,3,on,O
106015,3,[,O
106015,3,**2132-6-3**,O
106015,3,],O
106015,3,.,O
106015,3,-,O
106015,3,[,O
106015,3,**2132-7-11**,O
106015,3,],O
106015,3,:,O
106015,3,Hepatic,O
106015,3,resection,O
106015,3,of,O
106015,3,a,O
106015,3,1.7cm,O
106015,3,segment,O
106015,3,4a,O
106015,3,metastatic,O
106015,3,lesion,O
106015,3,by,O
106015,3,Dr.,O
106015,3,[,O
106015,3,**Last,O
106015,3,Name,O
106015,3,(,O
106015,3,STitle,O
106015,3,),O
106015,3,**,O
106015,3,],O
106015,3,.,O
106015,3,-,O
106015,3,[,O
106015,3,**2132-10-22**,O
106015,3,],O
106015,3,:,O
106015,3,Cycle,O
106015,3,1,O
106015,3,Day,O
106015,3,1,O
106015,3,5FU/LV,B-Drug
106015,3,for,O
106015,3,further,O
106015,3,adjuvant,O
106015,3,chemotherapy,B-Drug
106015,3,.,O
106015,3,Oxaliplatin,B-Drug
106015,3,eliminated,O
106015,3,due,O
106015,3,to,O
106015,3,neuropathy,B-ADE
106015,3,.,O
106015,4,The,O
106015,4,patient,O
106015,4,completed,O
106015,4,therapy,O
106015,4,in,O
106015,4,[,O
106015,4,**1-5**,O
106015,4,],O
106015,4,.,O
106015,4,-,O
106015,4,[,O
106015,4,**2132-11-26**,O
106015,4,],O
106015,4,:,O
106015,4,Hospital,O
106015,4,admission,O
106015,4,for,O
106015,4,SVC,B-Reason
106015,4,syndrome,I-Reason
106015,4,secondary,O
106015,4,to,O
106015,4,a,O
106015,4,catheter-associated,O
106015,4,thrombus,O
106015,4,causing,O
106015,4,occlusion,O
106015,4,of,O
106015,4,the,O
106015,4,SVC,O
106015,4,and,O
106015,4,bilateral,O
106015,4,brachiocephalic,O
106015,4,veins,O
106015,4,.,O
106015,4,The,O
106015,4,patient,O
106015,4,underwent,O
106015,4,TPA,O
106015,4,infusion,O
106015,4,followed,O
106015,4,by,O
106015,4,venous,O
106015,4,angioplasty,O
106015,4,with,O
106015,4,balloon,O
106015,4,dilation,O
106015,4,with,O
106015,4,resolution,O
106015,4,of,O
106015,4,symptoms,O
106015,4,.,O
106015,4,He,O
106015,4,was,O
106015,4,discharged,O
106015,4,on,O
106015,4,enoxaparin,B-Drug
106015,4,.,O
106015,4,-,O
106015,4,[,O
106015,4,**2133-8-3**,O
106015,4,],O
106015,4,:,O
106015,4,Initiation,O
106015,4,of,O
106015,4,ininotecan,B-Drug
106015,4,for,O
106015,4,recurrent,B-Reason
106015,4,disease,I-Reason
106015,4,.,O
106015,4,-,O
106015,4,[,O
106015,4,**2134-2-8**,O
106015,4,],O
106015,4,:,O
106015,4,Due,O
106015,4,to,O
106015,4,laboratory,O
106015,4,and,O
106015,4,radiographic,O
106015,4,evidence,O
106015,4,of,O
106015,4,disease,O
106015,4,progression,O
106015,4,",",O
106015,4,cetuximab,B-Drug
106015,4,was,O
106015,4,added,O
106015,4,to,O
106015,4,ininotecan,B-Drug
106015,4,;,O
106015,4,due,O
106015,4,to,O
106015,4,an,O
106015,4,allergic,B-Reason
106015,4,reaction,I-Reason
106015,4,",",O
106015,4,cetuximab,B-Drug
106015,4,was,O
106015,4,changed,O
106015,4,to,O
106015,4,panitumumab,B-Drug
106015,4,on,O
106015,4,[,O
106015,4,**2134-2-16**,O
106015,4,],O
106015,4,.,O
106015,4,.,O
106015,4,Other,O
106015,4,Past,O
106015,4,Medical,O
106015,4,History,O
106015,4,:,O
106015,4,1,O
106015,4,.,O
106015,4,Hypertension,O
106015,4,.,O
106015,4,2,O
106015,4,.,O
106015,4,Hyperlipidemia,O
106015,4,.,O
106015,4,3,O
106015,4,.,O
106015,4,ASCVD,O
106015,4,",",O
106015,4,status,O
106015,4,post,O
106015,4,MI,O
106015,4,in,O
106015,4,[,O
106015,4,**2111**,O
106015,4,],O
106015,4,.,O
106015,4,4,O
106015,4,.,O
106015,4,Status,O
106015,4,post,O
106015,4,appendectomy,O
106015,4,.,O
106015,4,5,O
106015,4,.,O
106015,4,Diabetes,O
106015,4,Social,O
106015,4,History,O
106015,4,:,O
106015,4,The,O
106015,4,patient,O
106015,4,lives,O
106015,4,alone,O
106015,4,and,O
106015,4,is,O
106015,4,divorced,O
106015,4,.,O
106015,4,He,O
106015,4,has,O
106015,4,three,O
106015,4,sons,O
106015,4,in,O
106015,4,their,O
106015,4,40s,O
106015,4,.,O
106015,4,He,O
106015,4,is,O
106015,4,a,O
106015,4,construction,O
106015,4,inspector,O
106015,4,.,O
106015,4,He,O
106015,4,denies,O
106015,4,alcohol,O
106015,4,use,O
106015,4,and,O
106015,4,drug,O
106015,4,use,O
106015,4,.,O
106015,4,He,O
106015,4,smoked,O
106015,4,one,O
106015,4,pack,O
106015,4,of,O
106015,4,cigarettes,O
106015,4,daily,O
106015,4,for,O
106015,4,30,O
106015,4,years,O
106015,4,before,O
106015,4,quitting,O
106015,4,.,O
106015,4,Family,O
106015,4,History,O
106015,4,:,O
106015,4,The,O
106015,4,patient,O
106015,4,'s,O
106015,4,paternal,O
106015,4,uncle,O
106015,4,had,O
106015,4,an,O
106015,4,abdominal,O
106015,4,cancer,O
106015,4,",",O
106015,4,details,O
106015,4,unknown,O
106015,4,.,O
106015,4,His,O
106015,4,father,O
106015,4,died,O
106015,4,of,O
106015,4,an,O
106015,4,MI,O
106015,4,.,O
106015,4,His,O
106015,4,mother,O
106015,4,died,O
106015,4,of,O
106015,4,[,O
106015,4,**Name,O
106015,4,(,O
106015,4,NI,O
106015,4,),O
106015,4,2481**,O
106015,4,],O
106015,4,disease,O
106015,4,.,O
106015,4,He,O
106015,4,has,O
106015,4,two,O
106015,4,brothers,O
106015,4,who,O
106015,4,are,O
106015,4,well,O
106015,4,.,O
106015,4,Physical,O
106015,4,Exam,O
106015,4,:,O
106015,4,Admission,O
106015,4,:,O
106015,4,GEN,O
106015,4,:,O
106015,4,awake,O
106015,4,",",O
106015,4,alert,O
106015,4,",",O
106015,4,NAD,O
106015,4,VS,O
106015,4,:,O
106015,4,97.6,O
106015,4,110/46,O
106015,4,88,O
106015,4,19,O
106015,4,100,O
106015,4,%,O
106015,4,2L,O
106015,4,HEENT,O
106015,4,:,O
106015,4,EOMI,O
106015,4,",",O
106015,4,MMM,O
106015,4,CV,O
106015,4,:,O
106015,4,irregularly,O
106015,4,irregular,O
106015,4,",",O
106015,4,no,O
106015,4,m/g/r,O
106015,4,PULM,O
106015,4,:,O
106015,4,crackles,O
106015,4,at,O
106015,4,RLL,O
106015,4,ABD,O
106015,4,:,O
106015,4,well,O
106015,4,healed,O
106015,4,scars,O
106015,4,on,O
106015,4,abdomen,O
106015,4,",",O
106015,4,soft,O
106015,4,",",O
106015,4,NT,O
106015,4,",",O
106015,4,ND,O
106015,4,LIMBS,O
106015,4,:,O
106015,4,no,O
106015,4,edema,O
106015,4,SKIN,O
106015,4,:,O
106015,4,erythema,O
106015,4,and,O
106015,4,excoriation,O
106015,4,over,O
106015,4,left,O
106015,4,antecubital,O
106015,4,fossa,O
106015,4,.,O
106015,4,Discharge,O
106015,4,:,O
106015,4,GEN,O
106015,4,:,O
106015,5,NAD,O
106015,5,",",O
106015,5,aaox3,O
106015,5,HEENT,O
106015,5,:,O
106015,5,MMM,O
106015,5,",",O
106015,5,oropharynx,O
106015,5,clear,O
106015,5,.,O
106015,5,CV,O
106015,5,:,O
106015,5,RRR,O
106015,5,",",O
106015,5,No,O
106015,5,m/r/g,O
106015,5,PULM,O
106015,5,:,O
106015,5,CTAB,O
106015,5,",",O
106015,5,decreased,O
106015,5,breath,O
106015,5,sounds,O
106015,5,at,O
106015,5,bases,O
106015,5,.,O
106015,5,Tunneled,O
106015,5,[,O
106015,5,**Name,O
106015,5,(,O
106015,5,NI,O
106015,5,),O
106015,5,2286**,O
106015,5,],O
106015,5,catheter,O
106015,5,noted,O
106015,5,on,O
106015,5,right,O
106015,5,chest,O
106015,5,",",O
106015,5,c/d/i,O
106015,5,ABD,O
106015,5,:,O
106015,5,Soft,O
106015,5,",",O
106015,5,distended,O
106015,5,",",O
106015,5,NT,O
106015,5,",",O
106015,5,+BS,O
106015,5,.,O
106015,5,EXTR,O
106015,5,:,O
106015,5,2+,O
106015,5,bilateral,O
106015,5,lower,O
106015,5,extremity,O
106015,5,edema,O
106015,5,",",O
106015,5,2+,O
106015,5,bilateral,O
106015,5,upper,O
106015,5,extremity,O
106015,5,edema,O
106015,5,",",O
106015,5,left,O
106015,5,>,O
106015,5,right,O
106015,5,2+,O
106015,5,DP,O
106015,5,pulses,O
106015,5,bilaterally,O
106015,5,.,O
106015,5,SKIN,O
106015,5,:,O
106015,5,blanching,O
106015,5,macules,O
106015,5,noted,O
106015,5,scattered,O
106015,5,across,O
106015,5,forearms,O
106015,5,and,O
106015,5,upper,O
106015,5,back,O
106015,5,.,O
106015,5,Pertinent,O
106015,5,Results,O
106015,5,:,O
106015,5,Admission,O
106015,5,labs,O
106015,5,:,O
106015,5,[,O
106015,5,**2134-4-19**,O
106015,5,],O
106015,5,11:35AM,O
106015,5,BLOOD,O
106015,5,WBC-2.8*,O
106015,5,RBC-3.30*,O
106015,5,Hgb-9.3*,O
106015,5,Hct-27.3*,O
106015,5,MCV-83,O
106015,5,MCH-28.3,O
106015,5,MCHC-34.2,O
106015,5,RDW-20.0*,O
106015,5,Plt,O
106015,5,Ct-283,O
106015,5,[,O
106015,5,**2134-4-19**,O
106015,5,],O
106015,5,11:35AM,O
106015,5,BLOOD,O
106015,5,PT-14.0*,O
106015,5,PTT-35.5*,O
106015,5,INR,O
106015,5,(,O
106015,5,PT,O
106015,5,),O
106015,5,-1.2*,O
106015,5,[,O
106015,5,**2134-4-19**,O
106015,5,],O
106015,5,11:35AM,O
106015,5,BLOOD,O
106015,5,Glucose-199*,O
106015,5,UreaN-23*,O
106015,5,Creat-1.3*,O
106015,5,Na-139,O
106015,5,K-4.0,O
106015,5,Cl-106,O
106015,5,HCO3-22,O
106015,5,AnGap-15,O
106015,5,[,O
106015,5,**2134-4-19**,O
106015,5,],O
106015,5,11:35AM,O
106015,5,BLOOD,O
106015,5,Calcium-8.3*,O
106015,5,Phos-2.4*,O
106015,5,Mg-0.8*,O
106015,5,.,O
106015,5,Discharge,O
106015,5,labs,O
106015,5,:,O
106015,5,Micro,O
106015,5,:,O
106015,5,[,O
106015,5,**4-20**,O
106015,5,],O
106015,5,:,O
106015,5,CLOSTRIDIUM,O
106015,5,DIFFICILE,O
106015,5,TOXIN,O
106015,5,A,O
106015,5,&,O
106015,5,B,O
106015,5,TEST,O
106015,5,(,O
106015,5,Final,O
106015,5,[,O
106015,5,**2134-4-21**,O
106015,5,],O
106015,5,),O
106015,5,:,O
106015,5,Feces,O
106015,5,negative,O
106015,5,for,O
106015,5,C.difficile,O
106015,5,toxin,O
106015,5,A,O
106015,5,&,O
106015,5,B,O
106015,5,by,O
106015,5,EIA,O
106015,5,.,O
106015,5,(,O
106015,5,Reference,O
106015,5,Range-Negative,O
106015,5,),O
106015,5,.,O
106015,5,FECAL,O
106015,5,CULTURE,O
106015,5,(,O
106015,5,Final,O
106015,5,[,O
106015,5,**2134-4-22**,O
106015,5,],O
106015,5,),O
106015,5,:,O
106015,5,NO,O
106015,5,SALMONELLA,O
106015,5,OR,O
106015,5,SHIGELLA,O
106015,5,FOUND,O
106015,5,.,O
106015,5,CAMPYLOBACTER,O
106015,5,CULTURE,O
106015,5,(,O
106015,5,Final,O
106015,5,[,O
106015,5,**2134-4-22**,O
106015,5,],O
106015,5,),O
106015,5,:,O
106015,5,NO,O
106015,5,CAMPYLOBACTER,O
106015,5,FOUND,O
106015,5,.,O
106015,5,.,O
106015,5,[,O
106015,5,**2134-5-4**,O
106015,5,],O
106015,5,12:58,O
106015,5,am,O
106015,5,STOOL,O
106015,5,CONSISTENCY,O
106015,5,:,O
106015,5,SOFT,O
106015,5,Source,O
106015,5,:,O
106015,5,Stool,O
106015,5,.,O
106015,5,**FINAL,O
106015,5,REPORT,O
106015,5,[,O
106015,5,**2134-5-4**,O
106015,5,],O
106015,5,**,O
106015,5,CLOSTRIDIUM,O
106015,5,DIFFICILE,O
106015,5,TOXIN,O
106015,5,A,O
106015,5,&,O
106015,5,B,O
106015,5,TEST,O
106015,5,(,O
106015,5,Final,O
106015,5,[,O
106015,5,**2134-5-4**,O
106015,5,],O
106015,5,),O
106015,5,:,O
106015,5,Feces,O
106015,5,negative,O
106015,5,for,O
106015,5,C.difficile,O
106015,5,toxin,O
106015,5,A,O
106015,5,&,O
106015,5,B,O
106015,5,by,O
106015,5,EIA,O
106015,5,.,O
106015,5,(,O
106015,5,Reference,O
106015,5,Range-Negative,O
106015,5,),O
106015,5,.,O
106015,5,[,O
106015,5,**2134-4-27**,O
106015,5,],O
106015,5,11:47,O
106015,5,am,O
106015,5,CATHETER,O
106015,5,TIP-IV,O
106015,5,**FINAL,O
106015,5,REPORT,O
106015,5,[,O
106015,5,**2134-4-29**,O
106015,5,],O
106015,5,**,O
106015,5,GRAM,O
106015,5,STAIN,O
106015,5,(,O
106015,5,Final,O
106015,5,[,O
106015,5,**2134-4-27**,O
106015,5,],O
106015,5,),O
106015,5,:,O
106015,5,TEST,O
106015,5,CANCELLED,O
106015,5,",",O
106015,5,PATIENT,O
106015,5,CREDITED,O
106015,5,.,O
106015,5,INAPPROPRIATE,O
106015,5,SPECIMEN,O
106015,5,FOR,O
106015,5,GRAM,O
106015,5,STAIN,O
106015,5,.,O
106015,5,WOUND,O
106015,5,CULTURE,O
106015,5,(,O
106015,5,Final,O
106015,5,[,O
106015,5,**2134-4-29**,O
106015,5,],O
106015,5,),O
106015,5,:,O
106015,6,STAPH,O
106015,6,AUREUS,O
106015,6,COAG,O
106015,6,+,O
106015,6,.,O
106015,6,>,O
106015,6,15,O
106015,6,colonies,O
106015,6,.,O
106015,6,Staphylococcus,O
106015,6,species,O
106015,6,may,O
106015,6,develop,O
106015,6,resistance,O
106015,6,during,O
106015,6,prolonged,O
106015,6,therapy,O
106015,6,with,O
106015,6,quinolones,O
106015,6,.,O
106015,6,Therefore,O
106015,6,",",O
106015,6,isolates,O
106015,6,that,O
106015,6,are,O
106015,6,initially,O
106015,6,susceptible,O
106015,6,may,O
106015,6,become,O
106015,6,resistant,O
106015,6,within,O
106015,6,three,O
106015,6,to,O
106015,6,four,O
106015,6,days,O
106015,6,after,O
106015,6,initiation,O
106015,6,of,O
106015,6,therapy,O
106015,6,.,O
106015,6,Testing,O
106015,6,of,O
106015,6,repeat,O
106015,6,isolates,O
106015,6,may,O
106015,6,be,O
106015,6,warranted,O
106015,6,.,O
106015,6,SENSITIVITIES,O
106015,6,:,O
106015,6,MIC,O
106015,6,expressed,O
106015,6,in,O
106015,6,MCG/ML,O
106015,6,_________________________________________________________,O
106015,6,STAPH,O
106015,6,AUREUS,O
106015,6,COAG,O
106015,6,+,O
106015,6,|,O
106015,6,CLINDAMYCIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,-,O
106015,6,<,O
106015,6,=0.25,O
106015,6,S,O
106015,6,ERYTHROMYCIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,<,O
106015,6,=0.25,O
106015,6,S,O
106015,6,GENTAMICIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,<,O
106015,6,=0.5,O
106015,6,S,O
106015,6,LEVOFLOXACIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,<,O
106015,6,=0.12,O
106015,6,S,O
106015,6,OXACILLIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,-,O
106015,6,0.5,O
106015,6,S,O
106015,6,TRIMETHOPRIM/SULFA,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,<,O
106015,6,=0.5,O
106015,6,S,O
106015,6,[,O
106015,6,**2134-4-24**,O
106015,6,],O
106015,6,2:47,O
106015,6,pm,O
106015,6,BLOOD,O
106015,6,CULTURE,O
106015,6,Source,O
106015,6,:,O
106015,6,Line-PICC,O
106015,6,.,O
106015,6,**FINAL,O
106015,6,REPORT,O
106015,6,[,O
106015,6,**2134-4-29**,O
106015,6,],O
106015,6,**,O
106015,6,Blood,O
106015,6,Culture,O
106015,6,",",O
106015,6,Routine,O
106015,6,(,O
106015,6,Final,O
106015,6,[,O
106015,6,**2134-4-29**,O
106015,6,],O
106015,6,),O
106015,6,:,O
106015,6,STAPH,O
106015,6,AUREUS,O
106015,6,COAG,O
106015,6,+,O
106015,6,.,O
106015,6,SENSITIVITIES,O
106015,6,PERFORMED,O
106015,6,ON,O
106015,6,CULTURE,O
106015,6,#,O
106015,6,294-1510A,O
106015,6,[,O
106015,6,**2134-4-23**,O
106015,6,],O
106015,6,.,O
106015,6,Consultations,O
106015,6,with,O
106015,6,ID,O
106015,6,are,O
106015,6,recommended,O
106015,6,for,O
106015,6,all,O
106015,6,blood,O
106015,6,cultures,O
106015,6,positive,O
106015,6,for,O
106015,6,Staphylococcus,O
106015,6,aureus,O
106015,6,and,O
106015,6,[,O
106015,6,**Female,O
106015,6,First,O
106015,6,Name,O
106015,6,(,O
106015,6,un,O
106015,6,),O
106015,6,564**,O
106015,6,],O
106015,6,species,O
106015,6,.,O
106015,6,STAPH,O
106015,6,AUREUS,O
106015,6,COAG,O
106015,6,+,O
106015,6,.,O
106015,6,SECOND,O
106015,6,MORPHOLOGY,O
106015,6,.,O
106015,6,Consultations,O
106015,6,with,O
106015,6,ID,O
106015,6,are,O
106015,6,recommended,O
106015,6,for,O
106015,6,all,O
106015,6,blood,O
106015,6,cultures,O
106015,6,positive,O
106015,6,for,O
106015,6,Staphylococcus,O
106015,6,aureus,O
106015,6,and,O
106015,6,[,O
106015,6,**Female,O
106015,6,First,O
106015,6,Name,O
106015,6,(,O
106015,6,un,O
106015,6,),O
106015,6,564**,O
106015,6,],O
106015,6,species,O
106015,6,.,O
106015,6,Staphylococcus,O
106015,6,species,O
106015,6,may,O
106015,6,develop,O
106015,6,resistance,O
106015,6,during,O
106015,6,prolonged,O
106015,6,therapy,O
106015,6,with,O
106015,6,quinolones,O
106015,6,.,O
106015,6,Therefore,O
106015,6,",",O
106015,6,isolates,O
106015,6,that,O
106015,6,are,O
106015,6,initially,O
106015,6,susceptible,O
106015,6,may,O
106015,6,become,O
106015,6,resistant,O
106015,6,within,O
106015,6,three,O
106015,6,to,O
106015,6,four,O
106015,6,days,O
106015,6,after,O
106015,6,initiation,O
106015,6,of,O
106015,6,therapy,O
106015,6,.,O
106015,6,Testing,O
106015,6,of,O
106015,6,repeat,O
106015,6,isolates,O
106015,6,may,O
106015,6,be,O
106015,6,warranted,O
106015,6,.,O
106015,6,SENSITIVITIES,O
106015,6,:,O
106015,6,MIC,O
106015,6,expressed,O
106015,6,in,O
106015,6,MCG/ML,O
106015,6,_________________________________________________________,O
106015,6,STAPH,O
106015,6,AUREUS,O
106015,6,COAG,O
106015,6,+,O
106015,6,|,O
106015,6,CLINDAMYCIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,-,O
106015,6,<,O
106015,6,=0.25,O
106015,6,S,O
106015,6,ERYTHROMYCIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,<,O
106015,6,=0.25,O
106015,6,S,O
106015,6,GENTAMICIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,<,O
106015,6,=0.5,O
106015,6,S,O
106015,6,LEVOFLOXACIN,B-Drug
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,6,--,O
106015,7,--,O
106015,7,0.25,O
106015,7,S,O
106015,7,OXACILLIN,B-Drug
106015,7,--,O
106015,7,--,O
106015,7,--,O
106015,7,--,O
106015,7,--,O
106015,7,--,O
106015,7,-,O
106015,7,1,O
106015,7,S,O
106015,7,TRIMETHOPRIM/SULFA,B-Drug
106015,7,--,O
106015,7,--,O
106015,7,<,O
106015,7,=0.5,O
106015,7,S,O
106015,7,Anaerobic,O
106015,7,Bottle,O
106015,7,Gram,O
106015,7,Stain,O
106015,7,(,O
106015,7,Final,O
106015,7,[,O
106015,7,**2134-4-26**,O
106015,7,],O
106015,7,),O
106015,7,:,O
106015,7,GRAM,O
106015,7,POSITIVE,O
106015,7,COCCI,O
106015,7,IN,O
106015,7,PAIRS,O
106015,7,AND,O
106015,7,CLUSTERS,O
106015,7,.,O
106015,7,Aerobic,O
106015,7,Bottle,O
106015,7,Gram,O
106015,7,Stain,O
106015,7,(,O
106015,7,Final,O
106015,7,[,O
106015,7,**2134-4-26**,O
106015,7,],O
106015,7,),O
106015,7,:,O
106015,7,GRAM,O
106015,7,POSITIVE,O
106015,7,COCCI,O
106015,7,IN,O
106015,7,CLUSTERS,O
106015,7,.,O
106015,7,[,O
106015,7,**4-19**,O
106015,7,],O
106015,7,ECG,O
106015,7,:,O
106015,7,Sinus,O
106015,7,rhythm,O
106015,7,with,O
106015,7,ventricular,O
106015,7,premature,O
106015,7,beat,O
106015,7,.,O
106015,7,Right,O
106015,7,bundle-branch,O
106015,7,block,O
106015,7,.,O
106015,7,Since,O
106015,7,the,O
106015,7,previous,O
106015,7,tracing,O
106015,7,of,O
106015,7,[,O
106015,7,**2132-11-27**,O
106015,7,],O
106015,7,inferior,O
106015,7,lead,O
106015,7,Q,O
106015,7,waves,O
106015,7,are,O
106015,7,less,O
106015,7,prominent,O
106015,7,.,O
106015,7,.,O
106015,7,[,O
106015,7,**4-19**,O
106015,7,],O
106015,7,CT,O
106015,7,torso,O
106015,7,:,O
106015,7,1,O
106015,7,.,O
106015,7,No,O
106015,7,evidence,O
106015,7,of,O
106015,7,pulmonary,O
106015,7,embolism,O
106015,7,or,O
106015,7,dissection,O
106015,7,.,O
106015,7,Multiple,O
106015,7,small,O
106015,7,pulmonary,O
106015,7,nodules,O
106015,7,are,O
106015,7,overall,O
106015,7,stable,O
106015,7,in,O
106015,7,size,O
106015,7,.,O
106015,7,Stable,O
106015,7,small,O
106015,7,right-sided,O
106015,7,pleural,O
106015,7,effusion,O
106015,7,.,O
106015,7,2,O
106015,7,.,O
106015,7,Stable,O
106015,7,extent,O
106015,7,of,O
106015,7,metastatic,O
106015,7,disease,O
106015,7,in,O
106015,7,the,O
106015,7,abdomen,O
106015,7,.,O
106015,7,3,O
106015,7,.,O
106015,7,Two,O
106015,7,small,O
106015,7,ventral,O
106015,7,wall,O
106015,7,hernias,O
106015,7,containing,O
106015,7,loops,O
106015,7,of,O
106015,7,small,O
106015,7,bowel,O
106015,7,",",O
106015,7,but,O
106015,7,no,O
106015,7,evidence,O
106015,7,of,O
106015,7,obstruction,O
106015,7,with,O
106015,7,oral,O
106015,7,contrast,O
106015,7,seen,O
106015,7,to,O
106015,7,the,O
106015,7,colon,O
106015,7,.,O
106015,7,4,O
106015,7,.,O
106015,7,Cholelithiasis,O
106015,7,.,O
106015,7,.,O
106015,7,[,O
106015,7,**2134-4-26**,O
106015,7,],O
106015,7,RUE,O
106015,7,ultrasound,O
106015,7,.,O
106015,7,INDICATION,O
106015,7,:,O
106015,7,72-year-old,O
106015,7,man,O
106015,7,with,O
106015,7,swollen,O
106015,7,left,O
106015,7,arm,O
106015,7,and,O
106015,7,left-sided,O
106015,7,Port-A-Cath,O
106015,7,.,O
106015,7,COMPARISON,O
106015,7,:,O
106015,7,None,O
106015,7,.,O
106015,7,TECHNIQUE,O
106015,7,:,O
106015,7,Grayscale,O
106015,7,and,O
106015,7,Doppler,O
106015,7,evaluation,O
106015,7,of,O
106015,7,left,O
106015,7,upper,O
106015,7,extremity,O
106015,7,.,O
106015,7,FINDINGS,O
106015,7,:,O
106015,7,Grayscale,O
106015,7,and,O
106015,7,Doppler,O
106015,7,evaluation,O
106015,7,of,O
106015,7,the,O
106015,7,left,O
106015,7,internal,O
106015,7,jugular,O
106015,7,",",O
106015,7,subclavian,O
106015,7,",",O
106015,7,axillary,O
106015,7,",",O
106015,7,basilic,O
106015,7,",",O
106015,7,and,O
106015,7,brachial,O
106015,7,veins,O
106015,7,demonstrate,O
106015,7,normal,O
106015,7,flow,O
106015,7,",",O
106015,7,compressibility,O
106015,7,",",O
106015,7,and,O
106015,7,response,O
106015,7,to,O
106015,7,augmentation,O
106015,7,wherever,O
106015,7,applicable,O
106015,7,.,O
106015,7,No,O
106015,7,intraluminal,O
106015,7,thrombus,O
106015,7,was,O
106015,7,identified,O
106015,7,.,O
106015,7,IMPRESSION,O
106015,7,:,O
106015,7,No,O
106015,7,evidence,O
106015,7,of,O
106015,7,DVT,O
106015,7,in,O
106015,7,the,O
106015,7,left,O
106015,7,upper,O
106015,7,extremity,O
106015,7,.,O
106015,7,[,O
106015,7,**2134-4-27**,O
106015,7,],O
106015,7,renal,O
106015,7,ultrasound,O
106015,7,:,O
106015,7,INDICATION,O
106015,7,:,O
106015,7,72,O
106015,7,year,O
106015,7,old,O
106015,7,man,O
106015,7,with,O
106015,7,acute,O
106015,7,kidney,O
106015,7,failure,O
106015,7,and,O
106015,7,sepsis,O
106015,7,.,O
106015,7,COMPARISON,O
106015,7,:,O
106015,7,CTA,O
106015,7,chest,O
106015,7,performed,O
106015,7,[,O
106015,7,**2134-4-19**,O
106015,7,],O
106015,7,.,O
106015,7,RENAL,O
106015,7,ULTRASOUND,O
106015,7,:,O
106015,7,The,O
106015,7,left,O
106015,7,kidney,O
106015,7,measures,O
106015,7,10.9,O
106015,7,cm,O
106015,7,.,O
106015,7,The,O
106015,7,right,O
106015,7,kidney,O
106015,7,measures,O
106015,7,10.7,O
106015,7,cm,O
106015,7,.,O
106015,7,There,O
106015,7,is,O
106015,7,no,O
106015,7,hydronephrosis,O
106015,7,",",O
106015,7,stone,O
106015,7,or,O
106015,7,mass,O
106015,8,in,O
106015,8,either,O
106015,8,kidney,O
106015,8,.,O
106015,8,The,O
106015,8,bladder,O
106015,8,is,O
106015,8,unremarkable,O
106015,8,.,O
106015,8,IMPRESSION,O
106015,8,:,O
106015,8,Unremarkable,O
106015,8,renal,O
106015,8,ultrasound,O
106015,8,without,O
106015,8,evidence,O
106015,8,of,O
106015,8,hydronephrosis,O
106015,8,.,O
106015,8,Brief,O
106015,8,Hospital,O
106015,8,Course,O
106015,8,:,O
106015,8,Mr.,O
106015,8,[,O
106015,8,**Known,O
106015,8,lastname,O
106015,8,1683**,O
106015,8,],O
106015,8,is,O
106015,8,a,O
106015,8,72,O
106015,8,yo,O
106015,8,M,O
106015,8,with,O
106015,8,h/o,O
106015,8,metastatic,O
106015,8,rectal,O
106015,8,CA,O
106015,8,and,O
106015,8,SVC,B-Reason
106015,8,syndrome,I-Reason
106015,8,",",O
106015,8,now,O
106015,8,resolved,O
106015,8,on,O
106015,8,lovenox,B-Drug
106015,8,tx,O
106015,8,",",O
106015,8,who,O
106015,8,was,O
106015,8,admitted,O
106015,8,to,O
106015,8,OMED,O
106015,8,on,O
106015,8,[,O
106015,8,**4-19**,O
106015,8,],O
106015,8,with,O
106015,8,intractable,B-ADE
106015,8,diarrhea,I-ADE
106015,8,thought,O
106015,8,[,O
106015,8,**3-2**,O
106015,8,],O
106015,8,chemo,B-Drug
106015,8,and,O
106015,8,transferred,O
106015,8,to,O
106015,8,the,O
106015,8,[,O
106015,8,**Hospital,O
106015,8,Unit,O
106015,8,Name,O
106015,8,153**,O
106015,8,],O
106015,8,on,O
106015,8,[,O
106015,8,**4-24**,O
106015,8,],O
106015,8,with,O
106015,8,BRBPR,O
106015,8,and,O
106015,8,hematemesis,O
106015,8,.,O
106015,8,GI,O
106015,8,was,O
106015,8,consulted,O
106015,8,and,O
106015,8,an,O
106015,8,EGD,O
106015,8,was,O
106015,8,performed,O
106015,8,on,O
106015,8,[,O
106015,8,**4-24**,O
106015,8,],O
106015,8,which,O
106015,8,showed,O
106015,8,diffuse,B-Reason
106015,8,erythema/ulceration,I-Reason
106015,8,",",I-Reason
106015,8,in,I-Reason
106015,8,esophagus,I-Reason
106015,8,",",I-Reason
106015,8,stomach,I-Reason
106015,8,",",I-Reason
106015,8,duodenum,I-Reason
106015,8,.,O
106015,8,This,O
106015,8,was,O
106015,8,thought,O
106015,8,due,O
106015,8,to,O
106015,8,irinotecan,B-Drug
106015,8,induced,O
106015,8,GI,B-ADE
106015,8,toxicity,I-ADE
106015,8,.,O
106015,8,They,O
106015,8,recommended,O
106015,8,PPI,B-Drug
106015,8,and,O
106015,8,carafate,B-Drug
106015,8,slurry,O
106015,8,.,O
106015,8,They,O
106015,8,were,O
106015,8,concerned,O
106015,8,that,O
106015,8,patient,O
106015,8,'s,O
106015,8,whole,O
106015,8,GI,O
106015,8,tract,O
106015,8,was,O
106015,8,diffusely,O
106015,8,inflamed,O
106015,8,as,O
106015,8,was,O
106015,8,seen,O
106015,8,on,O
106015,8,EGD,O
106015,8,and,O
106015,8,that,O
106015,8,the,O
106015,8,anastamotic,O
106015,8,site,O
106015,8,from,O
106015,8,his,O
106015,8,colectomy,O
106015,8,might,O
106015,8,be,O
106015,8,a,O
106015,8,bleeding,O
106015,8,source,O
106015,8,;,O
106015,8,a,O
106015,8,flex,O
106015,8,sigmoidoscopy,O
106015,8,was,O
106015,8,done,O
106015,8,on,O
106015,8,as,O
106015,8,well,O
106015,8,and,O
106015,8,showed,O
106015,8,as,O
106015,8,well,O
106015,8,diffuse,O
106015,8,ulceration,O
106015,8,and,O
106015,8,inflammation,B-Reason
106015,8,.,O
106015,8,HCTs,O
106015,8,and,O
106015,8,q6H,O
106015,8,hemodynamics,O
106015,8,remained,O
106015,8,stable,O
106015,8,throughout,O
106015,8,his,O
106015,8,hospital,O
106015,8,course,O
106015,8,.,O
106015,8,The,O
106015,8,patient,O
106015,8,was,O
106015,8,started,O
106015,8,on,O
106015,8,steroid,B-Drug
106015,8,enemas,O
106015,8,and,O
106015,8,mesalamine,B-Drug
106015,8,suppositories,O
106015,8,to,O
106015,8,decrease,O
106015,8,inflammation,B-Reason
106015,8,.,O
106015,8,The,O
106015,8,steroid,B-Drug
106015,8,enemas,O
106015,8,were,O
106015,8,discontinued,O
106015,8,",",O
106015,8,but,O
106015,8,the,O
106015,8,mesalamine,B-Drug
106015,8,suppositories,O
106015,8,were,O
106015,8,continued,O
106015,8,through,O
106015,8,to,O
106015,8,discharge,O
106015,8,.,O
106015,8,In,O
106015,8,total,O
106015,8,",",O
106015,8,he,O
106015,8,received,O
106015,8,3,O
106015,8,units,O
106015,8,PRBCs,B-Drug
106015,8,and,O
106015,8,2,O
106015,8,units,O
106015,8,of,O
106015,8,FFP,B-Drug
106015,8,.,O
106015,8,Stool,O
106015,8,cultures,O
106015,8,revealed,O
106015,8,no,O
106015,8,evidence,O
106015,8,of,O
106015,8,infection,O
106015,8,.,O
106015,8,.,O
106015,8,On,O
106015,8,[,O
106015,8,**4-24**,O
106015,8,],O
106015,8,",",O
106015,8,the,O
106015,8,patient,O
106015,8,was,O
106015,8,found,O
106015,8,to,O
106015,8,have,O
106015,8,that,O
106015,8,2/2,O
106015,8,bottles,O
106015,8,of,O
106015,8,his,O
106015,8,blood,O
106015,8,cultures,O
106015,8,drawn,O
106015,8,from,O
106015,8,his,O
106015,8,portacath,O
106015,8,were,O
106015,8,growing,O
106015,8,GPCs,O
106015,8,",",O
106015,8,speciation,O
106015,8,showed,O
106015,8,MSSA,O
106015,8,.,O
106015,8,He,O
106015,8,was,O
106015,8,treated,O
106015,8,for,O
106015,8,this,O
106015,8,with,O
106015,8,IV,O
106015,8,vancomycin,B-Drug
106015,8,",",O
106015,8,leaving,O
106015,8,the,O
106015,8,portacath,O
106015,8,and,O
106015,8,PICC,O
106015,8,in,O
106015,8,place,O
106015,8,.,O
106015,8,Daily,O
106015,8,surveillance,O
106015,8,blood,O
106015,8,cultures,O
106015,8,were,O
106015,8,performed,O
106015,8,and,O
106015,8,he,O
106015,8,was,O
106015,8,noted,O
106015,8,to,O
106015,8,clear,O
106015,8,his,O
106015,8,bacteremia,B-Reason
106015,8,on,O
106015,9,[,O
106015,9,**4-26**,O
106015,9,],O
106015,9,.,O
106015,9,Infectious,O
106015,9,diseases,O
106015,9,was,O
106015,9,consulted,O
106015,9,and,O
106015,9,the,O
106015,9,patient,O
106015,9,was,O
106015,9,switched,O
106015,9,to,O
106015,9,nafcillin,B-Drug
106015,9,with,O
106015,9,confirmation,O
106015,9,of,O
106015,9,MSSA,B-Reason
106015,9,.,O
106015,9,The,O
106015,9,port-a-cath,O
106015,9,was,O
106015,9,removed,O
106015,9,which,O
106015,9,was,O
106015,9,the,O
106015,9,source,O
106015,9,of,O
106015,9,infection,O
106015,9,.,O
106015,9,The,O
106015,9,patient,O
106015,9,however,O
106015,9,despite,O
106015,9,aggressive,O
106015,9,crystalloid,B-Drug
106015,9,and,O
106015,9,colloid,B-Drug
106015,9,(,O
106015,9,albumin,B-Drug
106015,9,",",O
106015,9,a,O
106015,9,further,O
106015,9,2,O
106015,9,units,O
106015,9,of,O
106015,9,blood,B-Drug
106015,9,),O
106015,9,resuscitation,B-Reason
106015,9,then,O
106015,9,developed,O
106015,9,sepsis,O
106015,9,related,O
106015,9,acute,O
106015,9,tubular,O
106015,9,necrosis,O
106015,9,.,O
106015,9,The,O
106015,9,patient,O
106015,9,became,O
106015,9,anuric,O
106015,9,and,O
106015,9,nephrology,O
106015,9,was,O
106015,9,consulted,O
106015,9,.,O
106015,9,Hemodialysis,O
106015,9,was,O
106015,9,initiated,O
106015,9,which,O
106015,9,the,O
106015,9,patient,O
106015,9,tolerated,O
106015,9,well,O
106015,9,",",O
106015,9,and,O
106015,9,a,O
106015,9,permanent,O
106015,9,tunneled,O
106015,9,catheter,O
106015,9,line,O
106015,9,was,O
106015,9,placed,O
106015,9,on,O
106015,9,[,O
106015,9,**2134-5-7**,O
106015,9,],O
106015,9,.,O
106015,9,The,O
106015,9,patient,O
106015,9,was,O
106015,9,started,O
106015,9,on,O
106015,9,phosphate,B-Drug
106015,9,binders,I-Drug
106015,9,",",O
106015,9,nephrocaps,B-Drug
106015,9,and,O
106015,9,erythropoeitin,B-Drug
106015,9,dosed,O
106015,9,at,O
106015,9,hemodialysis,O
106015,9,.,O
106015,9,The,O
106015,9,carafate,B-Drug
106015,9,was,O
106015,9,discontinued,O
106015,9,due,O
106015,9,to,O
106015,9,risk,O
106015,9,of,O
106015,9,aluminum,B-ADE
106015,9,toxicity,I-ADE
106015,9,.,O
106015,9,The,O
106015,9,nafcillin,B-Drug
106015,9,was,O
106015,9,also,O
106015,9,changed,O
106015,9,to,O
106015,9,Cefazolin,B-Drug
106015,9,dosed,O
106015,9,2mg,O
106015,9,at,O
106015,9,each,O
106015,9,[,O
106015,9,**Date,O
106015,9,Range,O
106015,9,2286**,O
106015,9,],O
106015,9,session,O
106015,9,for,O
106015,9,ease,B-Reason
106015,9,of,I-Reason
106015,9,administration,I-Reason
106015,9,and,O
106015,9,avoiding,B-Reason
106015,9,extra,I-Reason
106015,9,volume,I-Reason
106015,9,loading,I-Reason
106015,9,.,O
106015,9,Should,O
106015,9,the,O
106015,9,patient,O
106015,9,miss,O
106015,9,[,O
106015,9,**Initials,O
106015,9,(,O
106015,9,NamePattern4,O
106015,9,),O
106015,9,**,O
106015,9,],O
106015,9,[,O
106015,9,**Last,O
106015,9,Name,O
106015,9,(,O
106015,9,NamePattern4,O
106015,9,),O
106015,9,2286**,O
106015,9,],O
106015,9,session,O
106015,9,",",O
106015,9,extra,O
106015,9,doses,O
106015,9,of,O
106015,9,cefazolin,B-Drug
106015,9,should,O
106015,9,be,O
106015,9,administered,O
106015,9,as,O
106015,9,needed,O
106015,9,.,O
106015,9,The,O
106015,9,patient,O
106015,9,was,O
106015,9,planned,O
106015,9,for,O
106015,9,a,O
106015,9,28,O
106015,9,day,O
106015,9,course,O
106015,9,of,O
106015,9,cefazolin,B-Drug
106015,9,to,O
106015,9,be,O
106015,9,finished,O
106015,9,on,O
106015,9,[,O
106015,9,**2134-5-22**,O
106015,9,],O
106015,9,.,O
106015,9,.,O
106015,9,Other,O
106015,9,parts,O
106015,9,of,O
106015,9,his,O
106015,9,hospitalization,O
106015,9,are,O
106015,9,outlined,O
106015,9,by,O
106015,9,problem,O
106015,9,below,O
106015,9,:,O
106015,9,.,O
106015,9,#,O
106015,9,Hypotension/Tachycardia,O
106015,9,:,O
106015,9,In,O
106015,9,setting,O
106015,9,of,O
106015,9,extensive,O
106015,9,diahrrea,O
106015,9,.,O
106015,9,Ct,O
106015,9,torso,O
106015,9,is,O
106015,9,without,O
106015,9,PE,O
106015,9,or,O
106015,9,dissection,O
106015,9,.,O
106015,9,His,O
106015,9,BP,O
106015,9,initally,O
106015,9,recovered,O
106015,9,with,O
106015,9,500cc,O
106015,9,NS,B-Drug
106015,9,bolus,O
106015,9,.,O
106015,9,Once,O
106015,9,he,O
106015,9,had,O
106015,9,an,O
106015,9,episode,O
106015,9,of,O
106015,9,BRBPR,O
106015,9,",",O
106015,9,he,O
106015,9,became,O
106015,9,tacycardic,B-Reason
106015,9,to,I-Reason
106015,9,the,I-Reason
106015,9,140s,I-Reason
106015,9,",",O
106015,9,with,O
106015,9,BP,B-Reason
106015,9,90s/60s,I-Reason
106015,9,.,O
106015,9,He,O
106015,9,was,O
106015,9,bolused,O
106015,9,NS,B-Drug
106015,9,and,O
106015,9,given,O
106015,9,PRBC,B-Drug
106015,9,with,O
106015,9,improved,O
106015,9,HR,O
106015,9,to,O
106015,9,the,O
106015,9,110s,O
106015,9,",",O
106015,9,and,O
106015,9,BP,O
106015,9,to,O
106015,9,120s/80s,O
106015,9,.,O
106015,9,.,O
106015,9,#,O
106015,9,SVC,O
106015,9,syndrome,O
106015,9,:,O
106015,9,occurred,O
106015,9,in,O
106015,9,[,O
106015,9,**2132**,O
106015,9,],O
106015,9,.,O
106015,9,s/p,O
106015,9,TPA,O
106015,9,infusion,O
106015,9,followed,O
106015,9,by,O
106015,9,venous,O
106015,9,angioplasty,O
106015,9,with,O
106015,9,balloon,O
106015,9,dilation,O
106015,9,with,O
106015,9,resolution,O
106015,9,of,O
106015,9,symptoms,O
106015,9,.,O
106015,9,He,O
106015,9,was,O
106015,9,initially,O
106015,9,treated,O
106015,9,with,O
106015,10,lovenox,B-Drug
106015,10,(,O
106015,10,dose,O
106015,10,recalculated,O
106015,10,this,O
106015,10,admission,O
106015,10,",",O
106015,10,should,O
106015,10,be,O
106015,10,lower,O
106015,10,than,O
106015,10,his,O
106015,10,admission,O
106015,10,dose,O
106015,10,),O
106015,10,",",O
106015,10,but,O
106015,10,this,O
106015,10,was,O
106015,10,held,O
106015,10,secondary,O
106015,10,to,O
106015,10,GI,O
106015,10,bleed,O
106015,10,.,O
106015,10,This,O
106015,10,was,O
106015,10,not,O
106015,10,restarted,O
106015,10,at,O
106015,10,discharge,O
106015,10,given,O
106015,10,the,O
106015,10,patient,O
106015,10,'s,O
106015,10,renal,O
106015,10,failure,O
106015,10,.,O
106015,10,.,O
106015,10,#,O
106015,10,Diarrhea,B-Reason
106015,10,-,O
106015,10,the,O
106015,10,patient,O
106015,10,continued,O
106015,10,to,O
106015,10,have,O
106015,10,diarrhea,O
106015,10,that,O
106015,10,was,O
106015,10,controlled,O
106015,10,with,O
106015,10,titration,O
106015,10,of,O
106015,10,his,O
106015,10,anti-diarrheal,B-Drug
106015,10,medications,I-Drug
106015,10,.,O
106015,10,Infectious,O
106015,10,sources,O
106015,10,were,O
106015,10,ruled,O
106015,10,out,O
106015,10,and,O
106015,10,the,O
106015,10,cause,O
106015,10,was,O
106015,10,likely,O
106015,10,irinotecan,B-Drug
106015,10,-induced,O
106015,10,GI,B-ADE
106015,10,toxicity,I-ADE
106015,10,and,O
106015,10,radiation,B-ADE
106015,10,proctitis,I-ADE
106015,10,.,O
106015,10,#,O
106015,10,Generalized,O
106015,10,anasarca,O
106015,10,-,O
106015,10,The,O
106015,10,patient,O
106015,10,was,O
106015,10,noted,O
106015,10,to,O
106015,10,have,O
106015,10,an,O
106015,10,extremely,O
106015,10,low,O
106015,10,albumin,O
106015,10,on,O
106015,10,admission,O
106015,10,",",O
106015,10,likely,O
106015,10,related,O
106015,10,to,O
106015,10,poor,O
106015,10,nutrition,O
106015,10,due,O
106015,10,to,O
106015,10,his,O
106015,10,GI,O
106015,10,pathology,O
106015,10,.,O
106015,10,Albumins,O
106015,10,ranged,O
106015,10,between,O
106015,10,2.7,O
106015,10,and,O
106015,10,1.9,O
106015,10,.,O
106015,10,During,O
106015,10,volume,O
106015,10,resuscitation,O
106015,10,the,O
106015,10,patient,O
106015,10,became,O
106015,10,grossly,O
106015,10,edematous,O
106015,10,",",O
106015,10,and,O
106015,10,albumin,O
106015,10,was,O
106015,10,administered,O
106015,10,to,O
106015,10,little,O
106015,10,effect,O
106015,10,.,O
106015,10,His,O
106015,10,left,O
106015,10,upper,O
106015,10,extremity,O
106015,10,was,O
106015,10,noted,O
106015,10,to,O
106015,10,be,O
106015,10,more,O
106015,10,edematous,O
106015,10,than,O
106015,10,the,O
106015,10,rest,O
106015,10,of,O
106015,10,his,O
106015,10,body,O
106015,10,",",O
106015,10,and,O
106015,10,a,O
106015,10,LUE,O
106015,10,ultrasound,O
106015,10,was,O
106015,10,acquired,O
106015,10,.,O
106015,10,This,O
106015,10,demonstrated,O
106015,10,no,O
106015,10,evidence,O
106015,10,of,O
106015,10,clot,O
106015,10,.,O
106015,10,The,O
106015,10,patient,O
106015,10,slowly,O
106015,10,became,O
106015,10,less,O
106015,10,edematous,O
106015,10,when,O
106015,10,[,O
106015,10,**Year,O
106015,10,(,O
106015,10,4,O
106015,10,digits,O
106015,10,),O
106015,10,2286**,O
106015,10,],O
106015,10,was,O
106015,10,initiated,O
106015,10,and,O
106015,10,ultrafiltration,O
106015,10,was,O
106015,10,started,O
106015,10,.,O
106015,10,Mr.,O
106015,10,[,O
106015,10,**Known,O
106015,10,lastname,O
106015,10,1683**,O
106015,10,],O
106015,10,',O
106015,10,code,O
106015,10,status,O
106015,10,was,O
106015,10,confirmed,O
106015,10,as,O
106015,10,FULL,O
106015,10,CODE,O
106015,10,this,O
106015,10,hospital,O
106015,10,admission,O
106015,10,.,O
106015,10,Medications,O
106015,10,on,O
106015,10,Admission,O
106015,10,:,O
106015,10,DIPHENOXYLATE-ATROPINE,B-Drug
106015,10,-,O
106015,10,2.5,O
106015,10,mg-0.025,O
106015,10,mg,O
106015,10,Tablet,O
106015,10,-,O
106015,10,[,O
106015,10,**1-30**,O
106015,10,],O
106015,10,Tablet,O
106015,10,(,O
106015,10,s,O
106015,10,),O
106015,10,by,O
106015,10,mouth,O
106015,10,q6hr,O
106015,10,as,O
106015,10,needed,O
106015,10,for,O
106015,10,diarrhea,B-Reason
106015,10,ENOXAPARIN,O
106015,10,[,O
106015,10,LOVENOX,B-Drug
106015,10,],O
106015,10,-,O
106015,10,150,O
106015,10,mg/mL,O
106015,10,Syringe,O
106015,10,-,O
106015,10,Inject,O
106015,10,150,O
106015,10,mg,O
106015,10,once,O
106015,10,a,O
106015,10,day,O
106015,10,LISINOPRIL,B-Drug
106015,10,-,O
106015,10,(,O
106015,10,Prescribed,O
106015,10,by,O
106015,10,Other,O
106015,10,Provider,O
106015,10,),O
106015,10,-,O
106015,10,10,O
106015,10,mg,O
106015,10,Tablet,O
106015,10,-,O
106015,10,1,O
106015,10,Tablet,O
106015,10,(,O
106015,10,s,O
106015,10,),O
106015,10,by,O
106015,10,mouth,O
106015,10,daily,O
106015,10,METOPROLOL,B-Drug
106015,10,SUCCINATE,I-Drug
106015,10,[,O
106015,10,TOPROL,B-Drug
106015,10,XL,I-Drug
106015,10,],O
106015,10,-,O
106015,10,(,O
106015,10,Prescribed,O
106015,10,by,O
106015,10,Other,O
106015,10,Provider,O
106015,10,),O
106015,10,-,O
106015,10,100,O
106015,10,mg,O
106015,10,Tablet,O
106015,10,Sustained,O
106015,10,Release,O
106015,10,24,O
106015,10,hr,O
106015,10,-,O
106015,10,1,O
106015,10,Tablet,O
106015,10,(,O
106015,10,s,O
106015,10,),O
106015,10,by,O
106015,10,mouth,O
106015,10,daily,O
106015,10,METRONIDAZOLE,B-Drug
106015,10,[,O
106015,10,METROGEL,B-Drug
106015,10,],O
106015,10,-,O
106015,10,1,O
106015,10,%,O
106015,10,Gel,O
106015,10,-,O
106015,10,apply,O
106015,11,to,O
106015,11,rash,B-Reason
106015,11,twice,O
106015,11,a,O
106015,11,day,O
106015,11,PROCHLORPERAZINE,B-Drug
106015,11,MALEATE,I-Drug
106015,11,-,O
106015,11,10,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,-,O
106015,11,1,O
106015,11,Tablet,O
106015,11,(,O
106015,11,s,O
106015,11,),O
106015,11,by,O
106015,11,mouth,O
106015,11,q6hr,O
106015,11,as,O
106015,11,needed,O
106015,11,for,O
106015,11,nausea,B-Reason
106015,11,SIMVASTATIN,O
106015,11,-,O
106015,11,(,O
106015,11,Prescribed,O
106015,11,by,O
106015,11,Other,O
106015,11,Provider,O
106015,11,),O
106015,11,-,O
106015,11,20,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,-,O
106015,11,1,O
106015,11,Tablet,O
106015,11,(,O
106015,11,s,O
106015,11,),O
106015,11,by,O
106015,11,mouth,O
106015,11,daily,O
106015,11,LOPERAMIDE,B-Drug
106015,11,[,O
106015,11,IMODIUM,B-Drug
106015,11,A-D,I-Drug
106015,11,],O
106015,11,-,O
106015,11,2,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,-,O
106015,11,2,O
106015,11,Tablet,O
106015,11,(,O
106015,11,s,O
106015,11,),O
106015,11,by,O
106015,11,mouth,O
106015,11,q4he,O
106015,11,as,O
106015,11,needed,O
106015,11,for,O
106015,11,diarrhea,B-Reason
106015,11,PYRIDOXINE,O
106015,11,-,O
106015,11,(,O
106015,11,OTC,O
106015,11,),O
106015,11,-,O
106015,11,50,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,-,O
106015,11,2,O
106015,11,Tablet,O
106015,11,(,O
106015,11,s,O
106015,11,),O
106015,11,by,O
106015,11,mouth,O
106015,11,once,O
106015,11,a,O
106015,11,day,O
106015,11,Discharge,O
106015,11,Medications,O
106015,11,:,O
106015,11,1,O
106015,11,.,O
106015,11,Diphenoxylate-Atropine,B-Drug
106015,11,2.5-0.025,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,Sig,O
106015,11,:,O
106015,11,1-2,O
106015,11,Tablets,O
106015,11,PO,O
106015,11,Q6H,O
106015,11,(,O
106015,11,every,O
106015,11,6,O
106015,11,hours,O
106015,11,),O
106015,11,as,O
106015,11,needed,O
106015,11,for,O
106015,11,diarrhea,B-Reason
106015,11,.,O
106015,11,2,O
106015,11,.,O
106015,11,Compazine,B-Drug
106015,11,10,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,Sig,O
106015,11,:,O
106015,11,One,O
106015,11,(,O
106015,11,1,O
106015,11,),O
106015,11,Tablet,O
106015,11,PO,O
106015,11,every,O
106015,11,six,O
106015,11,(,O
106015,11,6,O
106015,11,),O
106015,11,hours,O
106015,11,as,O
106015,11,needed,O
106015,11,for,O
106015,11,nausea,B-Reason
106015,11,.,O
106015,11,3,O
106015,11,.,O
106015,11,Simvastatin,B-Drug
106015,11,20,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,Sig,O
106015,11,:,O
106015,11,One,O
106015,11,(,O
106015,11,1,O
106015,11,),O
106015,11,Tablet,O
106015,11,PO,O
106015,11,once,O
106015,11,a,O
106015,11,day,O
106015,11,.,O
106015,11,4,O
106015,11,.,O
106015,11,Loperamide,B-Drug
106015,11,2,O
106015,11,mg,O
106015,11,Capsule,O
106015,11,Sig,O
106015,11,:,O
106015,11,One,O
106015,11,(,O
106015,11,1,O
106015,11,),O
106015,11,Capsule,O
106015,11,PO,O
106015,11,every,O
106015,11,four,O
106015,11,(,O
106015,11,4,O
106015,11,),O
106015,11,hours,O
106015,11,as,O
106015,11,needed,O
106015,11,for,O
106015,11,diarrhea,B-Reason
106015,11,.,O
106015,11,5,O
106015,11,.,O
106015,11,Pyridoxine,B-Drug
106015,11,50,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,Sig,O
106015,11,:,O
106015,11,Two,O
106015,11,(,O
106015,11,2,O
106015,11,),O
106015,11,Tablet,O
106015,11,PO,O
106015,11,DAILY,O
106015,11,(,O
106015,11,Daily,O
106015,11,),O
106015,11,.,O
106015,11,6,O
106015,11,.,O
106015,11,Metoprolol,B-Drug
106015,11,Tartrate,I-Drug
106015,11,25,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,Sig,O
106015,11,:,O
106015,11,One,O
106015,11,(,O
106015,11,1,O
106015,11,),O
106015,11,Tablet,O
106015,11,PO,O
106015,11,TID,O
106015,11,(,O
106015,11,3,O
106015,11,times,O
106015,11,a,O
106015,11,day,O
106015,11,),O
106015,11,.,O
106015,11,7,O
106015,11,.,O
106015,11,Ipratropium,B-Drug
106015,11,Bromide,I-Drug
106015,11,0.02,O
106015,11,%,O
106015,11,Solution,O
106015,11,Sig,O
106015,11,:,O
106015,11,One,O
106015,11,(,O
106015,11,1,O
106015,11,),O
106015,11,neb,O
106015,11,Inhalation,O
106015,11,Q6H,O
106015,11,(,O
106015,11,every,O
106015,11,6,O
106015,11,hours,O
106015,11,),O
106015,11,as,O
106015,11,needed,O
106015,11,for,O
106015,11,shortness,B-Reason
106015,11,of,I-Reason
106015,11,breath,I-Reason
106015,11,or,O
106015,11,wheezing,B-Reason
106015,11,.,O
106015,11,8,O
106015,11,.,O
106015,11,Simethicone,B-Drug
106015,11,80,O
106015,11,mg,O
106015,11,Tablet,O
106015,11,",",O
106015,11,Chewable,O
106015,11,Sig,O
106015,11,:,O
106015,11,One,O
106015,11,(,O
106015,11,1,O
106015,11,),O
106015,11,Tablet,O
106015,11,",",O
106015,11,Chewable,O
106015,11,PO,O
106015,11,QID,O
106015,11,(,O
106015,11,4,O
106015,11,times,O
106015,11,a,O
106015,11,day,O
106015,11,),O
106015,11,as,O
106015,11,needed,O
106015,11,for,O
106015,11,bloating,B-Reason
106015,11,",",O
106015,11,gas,B-Reason
106015,11,.,O
106015,11,9,O
106015,11,.,O
106015,11,Heparin,B-Drug
106015,11,Flush,O
106015,11,(,O
106015,11,10,O
106015,11,units/ml,O
106015,11,),O
106015,11,2,O
106015,11,mL,O
106015,11,IV,O
106015,11,PRN,O
106015,11,line,O
106015,11,flush,O
106015,11,PICC,O
106015,11,",",O
106015,12,heparin,B-Drug
106015,12,dependent,O
106015,12,:,O
106015,12,Flush,O
106015,12,with,O
106015,12,10mL,O
106015,12,Normal,B-Drug
106015,12,Saline,I-Drug
106015,12,followed,O
106015,12,by,O
106015,12,Heparin,B-Drug
106015,12,as,O
106015,12,above,O
106015,12,daily,O
106015,12,and,O
106015,12,PRN,O
106015,12,per,O
106015,12,lumen,O
106015,12,.,O
106015,12,10,O
106015,12,.,O
106015,12,Ondansetron,B-Drug
106015,12,4,O
106015,12,mg,O
106015,12,IV,O
106015,12,Q8H,O
106015,12,:,O
106015,12,PRN,O
106015,12,nausea,B-Reason
106015,12,11,O
106015,12,.,O
106015,12,Prochlorperazine,B-Drug
106015,12,10,O
106015,12,mg,O
106015,12,IV,O
106015,12,Q6H,O
106015,12,:,O
106015,12,PRN,O
106015,12,nausea,B-Reason
106015,12,12,O
106015,12,.,O
106015,12,CefazoLIN,B-Drug
106015,12,2,O
106015,12,g,O
106015,12,IV,O
106015,12,HD,O
106015,12,PROTOCOL,O
106015,12,HD,O
106015,12,protocol,O
106015,12,",",O
106015,12,to,O
106015,12,be,O
106015,12,given,O
106015,12,during,O
106015,12,hemodialysis,O
106015,12,13,O
106015,12,.,O
106015,12,Diphenoxylate-Atropine,B-Drug
106015,12,2.5-0.025,O
106015,12,mg,O
106015,12,Tablet,O
106015,12,Sig,O
106015,12,:,O
106015,12,One,O
106015,12,(,O
106015,12,1,O
106015,12,),O
106015,12,Tablet,O
106015,12,PO,O
106015,12,Q6H,O
106015,12,(,O
106015,12,every,O
106015,12,6,O
106015,12,hours,O
106015,12,),O
106015,12,as,O
106015,12,needed,O
106015,12,for,O
106015,12,diarrhea,B-Reason
106015,12,.,O
106015,12,14,O
106015,12,.,O
106015,12,Calcium,B-Drug
106015,12,Acetate,I-Drug
106015,12,667,O
106015,12,mg,O
106015,12,Capsule,O
106015,12,Sig,O
106015,12,:,O
106015,12,One,O
106015,12,(,O
106015,12,1,O
106015,12,),O
106015,12,Capsule,O
106015,12,PO,O
106015,12,TID,O
106015,12,W/MEALS,O
106015,12,(,O
106015,12,3,O
106015,12,TIMES,O
106015,12,A,O
106015,12,DAY,O
106015,12,WITH,O
106015,12,MEALS,O
106015,12,),O
106015,12,.,O
106015,12,15,O
106015,12,.,O
106015,12,B,B-Drug
106015,12,Complex-Vitamin,I-Drug
106015,12,C-Folic,I-Drug
106015,12,Acid,I-Drug
106015,12,1,O
106015,12,mg,O
106015,12,Capsule,O
106015,12,Sig,O
106015,12,:,O
106015,12,One,O
106015,12,(,O
106015,12,1,O
106015,12,),O
106015,12,Cap,O
106015,12,PO,O
106015,12,DAILY,O
106015,12,(,O
106015,12,Daily,O
106015,12,),O
106015,12,.,O
106015,12,16,O
106015,12,.,O
106015,12,Heparin,B-Drug
106015,12,(,I-Drug
106015,12,Porcine,I-Drug
106015,12,),I-Drug
106015,12,"1,000",O
106015,12,unit/mL,O
106015,12,Solution,O
106015,12,Sig,O
106015,12,:,O
106015,12,4000-,O
106015,12,[,O
106015,12,**Numeric,O
106015,12,Identifier,O
106015,12,2249**,O
106015,12,],O
106015,12,Unit,O
106015,12,Injection,O
106015,12,PRN,O
106015,12,(,O
106015,12,as,O
106015,12,needed,O
106015,12,),O
106015,12,as,O
106015,12,needed,O
106015,12,for,O
106015,12,line,B-Reason
106015,12,flush,I-Reason
106015,12,:,O
106015,12,DWELL,O
106015,12,PRN,O
106015,12,line,B-Reason
106015,12,flush,I-Reason
106015,12,[,O
106015,12,**Numeric,O
106015,12,Identifier,O
106015,12,**,O
106015,12,],O
106015,12,Catheter,O
106015,12,(,O
106015,12,Tunneled,O
106015,12,2-Lumen,O
106015,12,),O
106015,12,:,O
106015,12,[,O
106015,12,**Numeric,O
106015,12,Identifier,O
106015,12,**,O
106015,12,],O
106015,12,NURSE,O
106015,12,ONLY,O
106015,12,:,O
106015,12,Withdraw,O
106015,12,4,O
106015,12,mL,O
106015,12,prior,O
106015,12,to,O
106015,12,flushing,O
106015,12,with,O
106015,12,10,O
106015,12,mL,O
106015,12,NS,B-Drug
106015,12,followed,O
106015,12,by,O
106015,12,Heparin,B-Drug
106015,12,as,O
106015,12,above,O
106015,12,according,O
106015,12,to,O
106015,12,volume,O
106015,12,per,O
106015,12,lumen,O
106015,12,.,O
106015,12,.,O
106015,12,17,O
106015,12,.,O
106015,12,Insulin,B-Drug
106015,12,Lispro,I-Drug
106015,12,100,O
106015,12,unit/mL,O
106015,12,Solution,O
106015,12,Sig,O
106015,12,:,O
106015,12,Sliding,O
106015,12,scale,O
106015,12,units,O
106015,12,Subcutaneous,O
106015,12,ASDIR,O
106015,12,(,O
106015,12,AS,O
106015,12,DIRECTED,O
106015,12,),O
106015,12,:,O
106015,12,2,O
106015,12,units,O
106015,12,for,O
106015,12,101-150,O
106015,12,4,O
106015,12,units,O
106015,12,for,O
106015,12,151-200,O
106015,12,6,O
106015,12,units,O
106015,12,for,O
106015,12,201-250,O
106015,12,8,O
106015,12,units,O
106015,12,for,O
106015,12,251-300,O
106015,12,10,O
106015,12,units,O
106015,12,for,O
106015,12,301-350,O
106015,12,12,O
106015,12,units,O
106015,12,for,O
106015,12,351-400,O
106015,12,.,O
106015,12,18,O
106015,12,.,O
106015,12,Mesalamine,B-Drug
106015,12,"1,000",O
106015,12,mg,O
106015,12,Suppository,O
106015,12,Sig,O
106015,12,:,O
106015,12,One,O
106015,12,(,O
106015,12,1,O
106015,12,),O
106015,12,Suppository,O
106015,12,Rectal,O
106015,12,DAILY,O
106015,12,(,O
106015,12,Daily,O
106015,12,),O
106015,12,.,O
106015,12,19,O
106015,12,.,O
106015,12,Pantoprazole,B-Drug
106015,12,40,O
106015,12,mg,O
106015,12,Tablet,O
106015,12,",",O
106015,12,Delayed,O
106015,12,Release,O
106015,12,(,O
106015,12,E.C,O
106015,12,.,O
106015,12,),O
106015,12,Sig,O
106015,12,:,O
106015,12,One,O
106015,12,(,O
106015,12,1,O
106015,12,),O
106015,12,Tablet,O
106015,12,",",O
106015,12,Delayed,O
106015,12,Release,O
106015,12,(,O
106015,12,E.C,O
106015,12,.,O
106015,12,),O
106015,12,PO,O
106015,12,Q24H,O
106015,12,(,O
106015,12,every,O
106015,12,24,O
106015,12,hours,O
106015,12,),O
106015,13,.,O
106015,13,20,O
106015,13,.,O
106015,13,Albuterol,B-Drug
106015,13,Sulfate,I-Drug
106015,13,2.5,O
106015,13,mg,O
106015,13,/3,O
106015,13,mL,O
106015,13,(,O
106015,13,0.083,O
106015,13,%,O
106015,13,),O
106015,13,Solution,O
106015,13,for,O
106015,13,Nebulization,O
106015,13,Sig,O
106015,13,:,O
106015,13,One,O
106015,13,(,O
106015,13,1,O
106015,13,),O
106015,13,nebulizer,O
106015,13,Inhalation,O
106015,13,Q6H,O
106015,13,(,O
106015,13,every,O
106015,13,6,O
106015,13,hours,O
106015,13,),O
106015,13,as,O
106015,13,needed,O
106015,13,for,O
106015,13,dyspnea,B-Reason
106015,13,.,O
106015,13,21,O
106015,13,.,O
106015,13,Epogen,B-Drug
106015,13,"10,000",O
106015,13,unit/mL,O
106015,13,Solution,O
106015,13,Sig,O
106015,13,:,O
106015,13,Hemodialysis,O
106015,13,Protocol,O
106015,13,Injection,O
106015,13,with,O
106015,13,each,O
106015,13,[,O
106015,13,**Numeric,O
106015,13,Identifier,O
106015,13,2286**,O
106015,13,],O
106015,13,session,O
106015,13,.,O
106015,13,22,O
106015,13,.,O
106015,13,Heparin,B-Drug
106015,13,(,I-Drug
106015,13,Porcine,I-Drug
106015,13,),I-Drug
106015,13,"5,000",O
106015,13,unit/mL,O
106015,13,Solution,O
106015,13,Sig,O
106015,13,:,O
106015,13,One,O
106015,13,(,O
106015,13,1,O
106015,13,),O
106015,13,mL,O
106015,13,Injection,O
106015,13,TID,O
106015,13,(,O
106015,13,3,O
106015,13,times,O
106015,13,a,O
106015,13,day,O
106015,13,),O
106015,13,.,O
106015,13,Discharge,O
106015,13,Disposition,O
106015,13,:,O
106015,13,Extended,O
106015,13,Care,O
106015,13,Facility,O
106015,13,:,O
106015,13,[,O
106015,13,**Hospital6,O
106015,13,979**,O
106015,13,],O
106015,13,-,O
106015,13,[,O
106015,13,**Location,O
106015,13,(,O
106015,13,un,O
106015,13,),O
106015,13,246**,O
106015,13,],O
106015,13,Discharge,O
106015,13,Diagnosis,O
106015,13,:,O
106015,13,Rectal,O
106015,13,cancer,O
106015,13,Diarrhea,O
106015,13,Sepsis,O
106015,13,Acute,O
106015,13,Renal,O
106015,13,Failure,O
106015,13,Discharge,O
106015,13,Condition,O
106015,13,:,O
106015,13,Mental,O
106015,13,Status,O
106015,13,:,O
106015,13,Clear,O
106015,13,and,O
106015,13,coherent,O
106015,13,Level,O
106015,13,of,O
106015,13,Consciousness,O
106015,13,:,O
106015,13,Alert,O
106015,13,and,O
106015,13,interactive,O
106015,13,Discharge,O
106015,13,Instructions,O
106015,13,:,O
106015,13,You,O
106015,13,were,O
106015,13,admitted,O
106015,13,to,O
106015,13,the,O
106015,13,hospital,O
106015,13,with,O
106015,13,diarrhea,O
106015,13,.,O
106015,13,We,O
106015,13,believe,O
106015,13,the,O
106015,13,diarrhea,B-ADE
106015,13,was,O
106015,13,a,O
106015,13,side,O
106015,13,effect,O
106015,13,of,O
106015,13,the,O
106015,13,chemotherapy,B-Drug
106015,13,you,O
106015,13,had,O
106015,13,received,O
106015,13,;,O
106015,13,it,O
106015,13,was,O
106015,13,treated,O
106015,13,with,O
106015,13,3,O
106015,13,anti-diarrheal,B-Drug
106015,13,medications,I-Drug
106015,13,.,O
106015,13,You,O
106015,13,also,O
106015,13,have,O
106015,13,a,O
106015,13,low,O
106015,13,blood,O
106015,13,pressure,O
106015,13,on,O
106015,13,admission,O
106015,13,",",O
106015,13,this,O
106015,13,was,O
106015,13,likely,O
106015,13,due,O
106015,13,to,O
106015,13,dehydration,O
106015,13,in,O
106015,13,the,O
106015,13,setting,O
106015,13,of,O
106015,13,diarrhea,O
106015,13,",",O
106015,13,and,O
106015,13,it,O
106015,13,improved,O
106015,13,with,O
106015,13,rehydration,B-Reason
106015,13,with,O
106015,13,IV,O
106015,13,fluids,B-Drug
106015,13,.,O
106015,13,Your,O
106015,13,diarrhea,O
106015,13,then,O
106015,13,became,O
106015,13,bloody,O
106015,13,",",O
106015,13,and,O
106015,13,you,O
106015,13,also,O
106015,13,had,O
106015,13,an,O
106015,13,episode,O
106015,13,of,O
106015,13,vomit,O
106015,13,with,O
106015,13,blood,O
106015,13,in,O
106015,13,it,O
106015,13,.,O
106015,13,As,O
106015,13,a,O
106015,13,result,O
106015,13,",",O
106015,13,you,O
106015,13,were,O
106015,13,transferred,O
106015,13,to,O
106015,13,the,O
106015,13,ICU,O
106015,13,.,O
106015,13,You,O
106015,13,had,O
106015,13,an,O
106015,13,upper,O
106015,13,endoscopy,O
106015,13,and,O
106015,13,a,O
106015,13,sigmoidoscopy,O
106015,13,",",O
106015,13,which,O
106015,13,showed,O
106015,13,ulceration,B-ADE
106015,13,in,I-ADE
106015,13,your,I-ADE
106015,13,esophagus,I-ADE
106015,13,",",I-ADE
106015,13,stomach,I-ADE
106015,13,and,I-ADE
106015,13,colon,I-ADE
106015,13,.,O
106015,13,This,O
106015,13,was,O
106015,13,thought,O
106015,13,to,O
106015,13,be,O
106015,13,due,O
106015,13,to,O
106015,13,the,O
106015,13,chemotherapy,B-Drug
106015,13,and,O
106015,13,radiation,O
106015,13,that,O
106015,13,you,O
106015,13,have,O
106015,13,been,O
106015,13,receiving,O
106015,13,for,O
106015,13,your,O
106015,13,colon,B-Reason
106015,13,cancer,I-Reason
106015,13,.,O
106015,13,.,O
106015,13,While,O
106015,13,admitted,O
106015,13,",",O
106015,13,you,O
106015,13,also,O
106015,13,had,O
106015,13,a,O
106015,13,severe,O
106015,13,bacterial,O
106015,13,infection,O
106015,13,that,O
106015,13,got,O
106015,13,into,O
106015,13,your,O
106015,13,blood,O
106015,13,.,O
106015,13,This,O
106015,13,severely,O
106015,13,damaged,O
106015,13,your,O
106015,13,kidneys,O
106015,13,",",O
106015,13,requiring,O
106015,13,you,O
106015,13,to,O
106015,13,be,O
106015,13,started,O
106015,13,on,O
106015,13,hemodialysis,O
106015,13,.,O
106015,13,You,O
106015,13,had,O
106015,13,a,O
106015,13,permanent,O
106015,13,[,O
106015,13,**Location,O
106015,13,(,O
106015,14,un,O
106015,14,),O
106015,14,2286**,O
106015,14,],O
106015,14,catheter,O
106015,14,placed,O
106015,14,and,O
106015,14,you,O
106015,14,will,O
106015,14,need,O
106015,14,to,O
106015,14,continue,O
106015,14,getting,O
106015,14,[,O
106015,14,**Location,O
106015,14,(,O
106015,14,un,O
106015,14,),O
106015,14,2286**,O
106015,14,],O
106015,14,3,O
106015,14,times,O
106015,14,a,O
106015,14,week,O
106015,14,.,O
106015,14,You,O
106015,14,were,O
106015,14,started,O
106015,14,on,O
106015,14,several,O
106015,14,new,O
106015,14,medications,O
106015,14,when,O
106015,14,you,O
106015,14,were,O
106015,14,admitted,O
106015,14,.,O
106015,14,Nephrocaps,B-Drug
106015,14,1,O
106015,14,capsule,O
106015,14,daily,O
106015,14,Phos-lo,B-Drug
106015,14,667mg,O
106015,14,three,O
106015,14,times,O
106015,14,a,O
106015,14,day,O
106015,14,mesalamine,B-Drug
106015,14,1000mg,O
106015,14,suppositories,O
106015,14,once,O
106015,14,a,O
106015,14,day,O
106015,14,Cefazolin,B-Drug
106015,14,2g,O
106015,14,given,O
106015,14,with,O
106015,14,hemodialysis,O
106015,14,pantoprazole,B-Drug
106015,14,40mg,O
106015,14,daily,O
106015,14,Erythropoetin,B-Drug
106015,14,given,O
106015,14,with,O
106015,14,hemodialysis,O
106015,14,Your,O
106015,14,metoprolol,B-Drug
106015,14,was,O
106015,14,changed,O
106015,14,from,O
106015,14,100mg,O
106015,14,once,O
106015,14,a,O
106015,14,day,O
106015,14,to,O
106015,14,25mg,O
106015,14,three,O
106015,14,times,O
106015,14,a,O
106015,14,day,O
106015,14,Your,O
106015,14,lisinopril,B-Drug
106015,14,and,O
106015,14,enoxaparin,B-Drug
106015,14,have,O
106015,14,been,O
106015,14,discontinued,O
106015,14,.,O
106015,14,Followup,O
106015,14,Instructions,O
106015,14,:,O
106015,14,You,O
106015,14,need,O
106015,14,to,O
106015,14,follow,O
106015,14,up,O
106015,14,with,O
106015,14,your,O
106015,14,outpatient,O
106015,14,oncologists,O
106015,14,",",O
106015,14,Drs,O
106015,14,.,O
106015,14,[,O
106015,14,**Last,O
106015,14,Name,O
106015,14,(,O
106015,14,STitle,O
106015,14,),O
106015,14,**,O
106015,14,],O
106015,14,and,O
106015,14,[,O
106015,14,**Name5,O
106015,14,(,O
106015,14,PTitle,O
106015,14,),O
106015,14,**,O
106015,14,],O
106015,14,[,O
106015,14,**Name5,O
106015,14,(,O
106015,14,PTitle,O
106015,14,),O
106015,14,**,O
106015,14,],O
106015,14,discuss,O
106015,14,any,O
106015,14,further,O
106015,14,treatment,O
106015,14,for,O
106015,14,you,O
106015,14,rectal,O
106015,14,cancer,O
106015,14,.,O
106015,14,Dr.,O
106015,14,[,O
106015,14,**First,O
106015,14,Name8,O
106015,14,(,O
106015,14,NamePattern2,O
106015,14,),O
106015,14,636**,O
106015,14,],O
106015,14,[,O
106015,14,**Last,O
106015,14,Name,O
106015,14,(,O
106015,14,NamePattern1,O
106015,14,),O
106015,14,**,O
106015,14,],O
106015,14,and,O
106015,14,Dr.,O
106015,14,[,O
106015,14,**Last,O
106015,14,Name,O
106015,14,(,O
106015,14,STitle,O
106015,14,),O
106015,14,**,O
106015,14,],O
106015,14,in,O
106015,14,Colorectal,O
106015,14,Cancer,O
106015,14,Clinic,O
106015,14,on,O
106015,14,[,O
106015,14,**5-31**,O
106015,14,],O
106015,14,at,O
106015,14,10,O
106015,14,AM,O
106015,14,.,O
106015,14,You,O
106015,14,can,O
106015,14,reach,O
106015,14,the,O
106015,14,office,O
106015,14,by,O
106015,14,calling,O
106015,14,[,O
106015,14,**Telephone/Fax,O
106015,14,(,O
106015,14,1,O
106015,14,),O
106015,14,22249**,O
106015,14,],O
106015,14,.,O
106015,14,Provider,O
106015,14,:,O
106015,14,[,O
106015,14,**First,O
106015,14,Name4,O
106015,14,(,O
106015,14,NamePattern1,O
106015,14,),O
106015,14,2747**,O
106015,14,],O
106015,14,[,O
106015,14,**Last,O
106015,14,Name,O
106015,14,(,O
106015,14,NamePattern1,O
106015,14,),O
106015,14,5780**,O
106015,14,],O
106015,14,",",O
106015,14,RN,O
106015,14,Phone,O
106015,14,:,O
106015,14,[,O
106015,14,**Telephone/Fax,O
106015,14,(,O
106015,14,1,O
106015,14,),O
106015,14,22**,O
106015,14,],O
106015,14,Date/Time,O
106015,14,:,O
106015,14,[,O
106015,14,**2134-5-24**,O
106015,14,],O
106015,14,10:00,O
106015,14,Completed,O
106015,14,by,O
106015,14,:,O
106015,14,[,O
106015,14,**2134-5-12**,O
106015,14,],O
